Health and Healthcare Systems

Starting in Norway, a new approach to Alzheimer's

Alzheimer's disease patient Isidora Tomaz, 82, sits in her armchair with two chairs placed in front of her by her husband Amilcar Dos Santos (unseen) to prevent her from falling to the ground in their house in Lisbon September 15, 2009. Several low income Portuguese families with Alzheimer's patients under their care are supported by Portugal's Alzheimer Association, a charity. Alzheimer Europe estimates the number of Alzheimer's patients in the European Union alone to surpass 7.0 million. September 21 is World Alzheimer's Day.

An Alzheimer's patient: "We are – in our whole personality – the sum of our memories." Image: REUTERS/Nacho Doce

Bjarte Reve
CEO, Nansen Neuroscience Network
May-Britt Moser
Professor, Nobel Laureate, NTNU
Edvard Moser
Professor, Nobel Laureate, NTNU
Christian Doeller
Professor, NTNU
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how Neuroscience is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:


September 21st is World Alzheimer’s Day, named for a disease that affects millions of lives around the world - and for which there is still no cure.

The traditional scientific approach to Alzheimer’s research has not been successful, and none of the major pharmaceutical companies have succeeded in developing a cure for dementia/Alzheimer’s.

We believe it’s time for a new approach to Alzheimer’s research. It’s time for an approach where basic scientists, translational researchers, clinicians, government, and industry work together. It’s time we combine cutting edge basic research, clinical research and patient care. It’s time, in other words, for a public-private partnership. We are impatient; we aim to start such a collaboration in Norway, and we invite collaborators to join us in this endeavour.

 The number of Alzheimer's patients worldwide is forecast to increase rapidly
The number of Alzheimer's patients worldwide is forecast to increase rapidly Image: The Alzheimer's Association

We need a new approach. David Cameron, former Prime Minister of the UK, once stated: “The truth is that dementia now stands along cancer as one of the greatest enemies of humanity. The cost to society and to the individuals and families affected are staggering.”

Dementia and Alzheimer’s are now the leading cause of death in the UK. It has been estimated that worldwide costs for Alzheimer’s may soon reach one trillion dollars. A cure would immediately impact the budget of every state in the country, not to mention millions of lives.

The Prime Minister of Norway, Erna Solberg, is committing resources and funding to the establishment of a national centre for research on brain diseases, connecting the best basic and translational neuroscientists with clinicians and industry. The purpose is to accelerate innovation and develop novel, innovative, and functional biomarkers for early detection and treatment of Alzheimer’s disease. We welcome this initiative, but believe we should take it one step further and connect our efforts to the best centres worldwide in a public-private research partnership.

We have a solid scientific base. We know where in the brain Alzheimer’s starts - a region called the entorhinal cortex. We also know a lot about the symptoms of the disease. Patients experience memory problems - for example, they get lost in an unknown city or forget where they left their keys. Over time, this can have devastating effects since we are – in our whole personality – the sum of our memories.

Excitingly, basic science in animal models made some key breakthroughs in Norway, culminating in a Nobel Prize for medicine awarded in 2014 for the discovery of grid cells in the entorhinal cortex - the key elements of the brain’s navigational and memory system.

Stage one of the endeavour led to the Nobel Prize. We are now entering stage two and want to bring the Nobel Prize to the clinic and the society. The Nobel Prize-awarded findings on grid cells and the fundamental principles of neural coding are a possible window into understanding Alzheimer’s, and we want to bring that work into the clinic.

Have you read?

Our recent work has already made the first steps. Firstly, we detected grid cell population activity in the human brain by using non-invasive brain imaging techniques (Doeller et al, Nature 2010). Secondly, and crucially, with these tools we can now also detect a dysfunction in the entorhinal system decades before potential disease onset in humans at genetic risk for Alzheimer’s disease (Kunz et al, Science 2015).

So what are the next steps? Our new research centre, the Braathen-Kavli Center at NTNU, will pursue translational neuroscience research investigating firstly the key neural coding principles in the human brain and secondly, conditions of the breakdown of neural coding in Alzheimer’s.

We will establish a National Research Centre on Brain Diseases and we invite the best neuroscientists, clinicians, funders, and industry to join us in a collaborative approach to tackle and defeat Alzheimer’s disease. We welcome the World Economic Forum as a neutral platform for setting up such a public-private partnership.

This article is part of a series by the Global Future Council on Neurotechnology and Brain Sciences.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Health and Healthcare SystemsWellbeing and Mental Health
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Gender and health equity will only come with universal access to eye health – here's why

Dr. Princess Ifeoma Ike

May 24, 2024

About Us



Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum